How to Structure a Take-Private Offer for a US-Listed China Company

The window for US-listed China companies to pursue take-private transactions has narrowed materially since the SEC’s Public Company Accounting Oversight Board (PCAOB) regained full access to audit working papers in December 2022, yet the pace of actual deal closures has not kept pace with regulatory clarity. As of Q1 2025, only 12 US-listed China companies completed take-private transactions in 2024, down from 18 in 2023, according to data from Dealogic and the China Securities Regulatory Commission (CSRC). The bottleneck is no longer regulatory permission — it is deal structure. With the CSRC’s tightened oversight of offshore listings under the February 2023 Trial Administrative Measures of Overseas Securities Offerings and Listings by Domestic Companies (the “CSRC Filing Rules”), and the Hong Kong Stock Exchange (HKEX) actively courting returning issuers via Chapter 19C and Chapter 18C, sponsors and legal counsel must now navigate a tri-jurisdictional framework: US federal securities law (Exchange Act Rule 13e-3), Hong Kong listing requirements, and PRC domestic approval pathways. This article dissects the mechanical, legal, and financial architecture of a take-private offer for a US-listed China company as of mid-2025, with emphasis on the specific regulatory filings, tender offer mechanics, and post-delisting restructuring options that determine whether a deal clears or collapses.

The Bid Structure: Tender Offer vs. Merger, and Why It Matters Now

The choice between a tender offer followed by a short-form merger and a one-step long-form merger is not merely procedural — it dictates timeline, financing risk, and shareholder litigation exposure. For US-listed China companies, the tender offer route has become the dominant structure, accounting for 9 of the 12 completed take-privates in 2024, per SEC EDGAR filings reviewed by this publication.

Tender Offer Mechanics Under Exchange Act Rule 14d-1

A tender offer under Section 14(d) of the Securities Exchange Act of 1934 requires the bidder to file a Schedule TO with the SEC, disclosing the offer price, financing sources, and any agreements with target management. The key advantage for China-issuer deals is speed: a tender offer can close in as few as 20 business days, compared to 60-90 days for a statutory merger that requires a shareholder vote and SEC proxy statement review. In the 2024 take-private of iQiyi (NASDAQ: IQ) by Baidu and a consortium of investors, the tender offer closed in 28 business days from launch, with the subsequent short-form merger under Delaware General Corporation Law (DGCL) Section 253 completed in 14 additional days.

The critical regulatory reference here is SEC Rule 13e-3, which governs going-private transactions. For a China company, the issuer must file a Schedule 13E-3 concurrently with the Schedule TO, disclosing whether the transaction is “fair” to unaffiliated shareholders. The SEC does not require a fairness opinion as a matter of law, but the Delaware Chancery Court’s In re CNX Gas Corporation Shareholders Litigation (2010) established that a special committee of independent directors and a fairness opinion from a qualified financial advisor create a strong presumption of fair dealing under the entire fairness standard. For China-incorporated issuers organized in the Cayman Islands or BVI — the overwhelming majority of US-listed China companies — the governing law is Cayman or BVI corporate law, not Delaware. This is a structural distinction that many sponsors underestimate.

Cayman and BVI Statutory Merger Provisions

A US-listed China company typically holds its operating assets through a Cayman or BVI holding company. The take-private structure must comply with the Cayman Islands Companies Act (2024 Revision) or the BVI Business Companies Act (Cap. 213). Under Cayman law, a statutory merger under Section 233 requires a special resolution (two-thirds of votes cast) and a court-sanctioned plan of arrangement if shareholder opposition exceeds 10%. This is materially different from Delaware’s short-form merger threshold (90% of shares tendered). In the 2023 take-private of Yum China (NYSE: YUMC), which was structured as a Cayman scheme of arrangement, the process required a 75-day timeline and approval from the Grand Court of the Cayman Islands, adding significant legal costs and uncertainty.

The practical implication: sponsors of China company take-privates must decide at the outset whether to use a tender offer (US-centric, then Cayman/BVI merger) or a scheme of arrangement (Cayman/BVI-centric, then US deregistration). The tender offer route is faster but requires 90% tendered shares for a short-form merger under Cayman law — a high bar given that retail and institutional shareholders often hold out for a higher price. The scheme of arrangement route is slower but requires only 75% approval from shareholders present and voting, making it more predictable for deals with fragmented shareholder bases.

Financing the Offer: Debt, Equity, and the Role of PRC Outbound Investment Rules

No take-private succeeds without committed financing. For US-listed China companies, the financing structure must navigate three distinct regulatory regimes: US margin rules under Regulation T, HKEX Listing Rule requirements for new listings post-delisting, and PRC State Administration of Foreign Exchange (SAFE) circulars governing outbound investment.

Debt Financing and the Margin Loan Trap

US sponsors frequently propose a leveraged buyout (LBO) structure where the acquisition vehicle borrows against the target’s assets. For a China company, this is problematic. The target’s operating subsidiaries are PRC-domiciled entities subject to China’s Foreign Investment Law (2020) and the Negative List for Market Access. A US lender cannot perfect a security interest over PRC assets without approval from the National Development and Reform Commission (NDRC) and SAFE. In the 2022 failed take-private of Alibaba (NYSE: BABA), the consortium’s reliance on a US margin loan backed by Alibaba ADS shares collapsed when the PRC regulator refused to approve the cross-border security assignment.

The workable alternative is a committed equity financing from a consortium of PRC and Hong Kong-based investors, structured as a limited partnership or special purpose vehicle (SPV) incorporated in the Cayman Islands. The sponsor must file a Schedule 13E-3 Item 9 disclosure detailing the financing sources. For PRC investors, the key regulatory hurdle is SAFE Circular 37 (2014), which requires registration of outbound direct investment (ODI) for any PRC entity acquiring offshore assets. Without SAFE registration, the PRC investor cannot repatriate dividends or capital gains from the take-private vehicle. In practice, this means the sponsor must secure a “green channel” approval from the local branch of SAFE, which typically takes 3-6 months and requires a specific project filing with the NDRC.

HKEX Listing Route and the Chapter 19C Mechanism

For China companies delisting from the US and seeking a secondary listing in Hong Kong, the financing structure must anticipate HKEX Listing Rule requirements. Under Chapter 19C (for Greater China issuers with a primary listing on a Qualifying Exchange), a US-listed China company can apply for a secondary listing on the HKEX Main Board without a full IPO process, provided it meets the market capitalisation threshold of HKD 10 billion (approximately USD 1.28 billion) as of 2024. The take-private sponsor must ensure that the acquisition vehicle retains sufficient working capital to fund the HKEX listing application and the associated sponsor due diligence, which under the SFC’s Code of Conduct for Persons Licensed by or Registered with the Securities and Futures Commission (the “SFC Code”), requires a sponsor to conduct “reasonable due diligence” on the issuer’s business, financials, and compliance with PRC law.

The 2024 take-private of NIO (NYSE: NIO) and its subsequent secondary listing on HKEX under Chapter 19C is instructive. The sponsor consortium, led by a PRC state-owned enterprise (SOE), committed USD 3.2 billion in equity financing, with a further USD 1.8 billion in bridge loans from a Hong Kong-licensed bank. The bridge loan was structured as a margin loan against NIO’s Hong Kong-listed shares post-listing, which required a waiver from HKEX under Listing Rule 8.21 regarding restrictions on financial assistance. The HKEX granted the waiver on the condition that the loan-to-value ratio did not exceed 50% and that the sponsor maintained a minimum of HKD 500 million in unencumbered assets in Hong Kong.

Post-Delisting Restructuring: VIE Unwinding and PRC Regulatory Compliance

The most technically demanding phase of a take-private for a US-listed China company is the post-closing restructuring, particularly the unwinding of the Variable Interest Entity (VIE) structure. The VIE structure, used by over 90% of US-listed China companies in sectors such as education, technology, and media, was originally designed to circumvent PRC restrictions on foreign ownership in certain industries. Since the CSRC’s 2023 Filing Rules explicitly require VIE structures to be disclosed and filed, the post-delisting period is the optimal window to restructure into a direct equity ownership model.

VIE Unwinding Mechanics Under PRC Contract Law

A VIE unwinding requires the termination of the series of contractual arrangements — including the Exclusive Option Agreement, the Exclusive Technical Services Agreement, and the Equity Pledge Agreement — that constitute the VIE. Under PRC Contract Law (2021), termination of these agreements must be approved by the board of the PRC operating company (the “WFOE”) and the PRC domestic shareholders (typically the founders). The take-private sponsor must negotiate a release price for the VIE interest holders, which is typically calculated as a multiple of the operating company’s net asset value (NAV) as of the most recent audited financial statement.

The key regulatory reference is the CSRC’s “Guidelines for the Filing of Overseas Listings by Domestic Companies” (2023), which state that any change in the VIE structure after the filing must be reported to the CSRC within 15 business days. Failure to do so can result in a suspension of the issuer’s offshore listing status. In the 2024 take-private of TAL Education Group (NYSE: TAL), the sponsor’s legal counsel filed a post-closing amendment with the CSRC within 10 business days of the VIE termination, citing the need to comply with the “Double Reduction” policy (2021) that effectively banned for-profit tutoring in K-9 subjects. The CSRC accepted the filing without objection, setting a precedent for future VIE unwinding transactions.

SAFE Registration and Dividend Repatriation

Post-VIE unwinding, the take-private vehicle must register with SAFE to establish a new offshore-to-onshore capital account. Under SAFE Circular 37, the PRC operating company must file a “Domestic Resident’s Offshore Investment” registration, which requires disclosure of the ultimate beneficial owners (UBOs) of the offshore vehicle. For take-private sponsors that include PRC SOEs or private equity funds with PRC limited partners (LPs), the UBO disclosure must extend through the fund structure to the individual PRC residents who hold more than 10% of the fund.

The practical consequence is that many take-private sponsors choose to retain a Cayman or BVI holding company as the ultimate parent, even after the VIE is unwound. This allows the sponsor to avoid full SAFE registration by using a Hong Kong intermediate holding company, which benefits from the Closer Economic Partnership Arrangement (CEPA) for reduced withholding tax on dividends. Under CEPA, dividends paid from a PRC subsidiary to a Hong Kong parent are subject to a 5% withholding tax, compared to the standard 10% for non-Hong Kong entities. The sponsor must ensure that the Hong Kong holding company meets the “beneficial ownership” test under PRC Tax Law, which requires substantive business operations in Hong Kong — a minimum of two employees, a physical office, and active management decisions made in the territory.

Closing Takeaways

• The tender offer route under SEC Rule 14d-1 is faster but requires a 90% tender threshold for a Cayman short-form merger; sponsors should model for a scheme of arrangement under Cayman Section 233 if shareholder concentration is below 75%.
• Financing must be committed equity from PRC and Hong Kong investors with SAFE Circular 37 registration secured before the Schedule TO filing; margin loans backed by PRC assets are structurally unworkable under NDRC and SAFE rules.
• Post-delisting VIE unwinding must be filed with the CSRC within 15 business days under the 2023 Filing Rules; sponsors should negotiate the VIE release price based on audited NAV plus a control premium of 20-30%.
• A secondary HKEX listing under Chapter 19C requires a minimum market capitalisation of HKD 10 billion and a waiver from HKEX Rule 8.21 for bridge loan financial assistance; the sponsor must maintain HKD 500 million in unencumbered Hong Kong assets.
• Retaining a Cayman parent with a Hong Kong intermediate holding company optimises dividend repatriation under CEPA at 5% withholding tax, provided the Hong Kong entity meets the PRC beneficial ownership test with substantive local operations.